Veena Sangwan

Title: Veena Sangwan: Innovator in Pancreatic Cancer Therapy

Introduction

Veena Sangwan is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of medical research, particularly in the area of pancreatic cancer therapy and diagnosis. Her innovative approach aims to improve treatment outcomes for patients suffering from this challenging disease.

Latest Patents

Veena Sangwan holds a patent for a novel method of treating pancreatic cancer and pancreatitis. This method utilizes a combination of a dopamine receptor antagonist, specifically pimozide, haloperidol, and/or L-741,626, along with 2-deoxy-D-glucose and atorvastatin. The treatment may also be used in conjunction with gemcitabine, enhancing its effectiveness in combating pancreatic cancer.

Career Highlights

Throughout her career, Veena has worked with esteemed institutions such as McGill University and the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts. Her research has focused on developing innovative therapies that address critical health challenges, particularly in oncology.

Collaborations

Veena has collaborated with notable colleagues, including Pouria Jandaghi and Yasser Riaz Alhosseini. These partnerships have contributed to her research and the advancement of her patented therapies.

Conclusion

Veena Sangwan's work in pancreatic cancer therapy exemplifies her dedication to improving patient care through innovative research. Her contributions to the field are invaluable and highlight the importance of continued innovation in medical science.